Doseology Sciences Inc. (DOSEF)
USD 0.14
(0.0%)
USD 0.14
(0.0%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2022 | -1.78 Million CAD | 8.14% |
| 2021 | -1.93 Million CAD | -19.23% |
| 2020 | -1.62 Million CAD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 Q2 | -111.64 Thousand CAD | -42.98% |
| 2023 Q1 | -78.08 Thousand CAD | 93.19% |
| 2022 FY | -1.78 Million CAD | 8.14% |
| 2022 Q3 | -110.56 Thousand CAD | 41.28% |
| 2022 Q2 | -188.29 Thousand CAD | 44.63% |
| 2022 Q1 | -340.07 Thousand CAD | 37.93% |
| 2022 Q4 | -1.14 Million CAD | -937.49% |
| 2021 Q3 | -537.45 Thousand CAD | 1.07% |
| 2021 Q1 | -310.67 Thousand CAD | 50.71% |
| 2021 Q2 | -543.28 Thousand CAD | -74.87% |
| 2021 Q4 | -547.9 Thousand CAD | -1.94% |
| 2021 FY | -1.93 Million CAD | -19.23% |
| 2020 Q4 | -630.31 Thousand CAD | -55.44% |
| 2020 Q3 | -405.5 Thousand CAD | 3.02% |
| 2020 Q2 | -418.13 Thousand CAD | -142.25% |
| 2020 Q1 | -172.6 Thousand CAD | 0.0% |
| 2020 FY | -1.62 Million CAD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Eiger BioPharmaceuticals, Inc. | -74.96 Million USD | 97.623% |
| Nanobac Pharmaceuticals, Incorporated | -6.57 Million USD | 72.909% |
| SQZ Biotechnologies Company | -79.46 Million USD | 97.758% |
| Evofem Biosciences, Inc. | 52.97 Million USD | 103.363% |
| Santhera Pharmaceuticals Holding AG | 65.13 Million USD | 102.735% |
| Mesoblast Limited | -87.95 Million USD | 97.975% |
| Propanc Biopharma, Inc. | -1.82 Million USD | 2.141% |
| Genus plc | 7.9 Million USD | 122.551% |
| VioQuest Pharmaceuticals, Inc. | -10.89 Million USD | 83.643% |
| CNBX Pharmaceuticals Inc. | -3.71 Million USD | 51.983% |
| Marizyme, Inc. | -65.34 Million USD | 97.274% |
| ContraFect Corporation | -65.15 Million USD | 97.266% |
| Nymox Pharmaceutical Corporation | -8.84 Million USD | 79.856% |
| PsyBio Therapeutics Corp. | -4.88 Million USD | 63.538% |
| Sienna Biopharmaceuticals, Inc. | - USD | Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | -1.72 Million USD | -3.131% |
| Intellipharmaceutics International Inc. | -2.89 Million USD | 38.406% |
| AXIM Biotechnologies, Inc. | -8.05 Million USD | 77.896% |
| MultiCell Technologies, Inc. | -380.07 USD | -468641.021% |
| Accustem Sciences Inc. | -3.74 Million USD | 52.447% |
| RVL Pharmaceuticals plc | -51.69 Million USD | 96.554% |
| EV Biologics, Inc. | -1.26 Million USD | -40.596% |
| Q BioMed Inc. | -2.05 Million USD | 13.184% |
| Emmaus Life Sciences, Inc. | -3.73 Million USD | 52.276% |
| Neon Bloom, Inc. | -632.4 Thousand USD | -181.708% |
| Mosaic ImmunoEngineering Inc. | -2.38 Million USD | 25.173% |
| Biomind Labs Inc. | -1.21 Million USD | -46.711% |
| TetraLogic Pharmaceuticals Corporation | - USD | Infinity% |
| Pharming Group N.V. | -10.54 Million USD | 83.11% |
| Oncotelic Therapeutics, Inc. | -7.9 Million USD | 77.458% |
| Skye Bioscience, Inc. | -37.64 Million USD | 95.267% |
| Therapeutic Solutions International, Inc. | -2.16 Million USD | 17.894% |
| THC Farmaceuticals, Inc. | -14.97 Thousand USD | -11795.994% |
| Arch Therapeutics, Inc. | -6.98 Million USD | 74.487% |
| IMV Inc. | -36.48 Million USD | 95.117% |
| Acro Biomedical Co., Ltd. | -15.87 Million USD | 88.775% |
| Curative Biotechnology, Inc. | -5.81 Million USD | 69.375% |
| GB Sciences, Inc. | -1.36 Million USD | -30.835% |
| Alpha Cognition Inc. | -13.77 Million USD | 87.065% |
| HST Global, Inc. | -146.21 Thousand USD | -1118.483% |
| CSL Limited | 2.64 Billion USD | 100.067% |
| Halberd Corporation | -79.67 Thousand USD | -2135.986% |
| Enzolytics Inc. | -2.17 Million USD | 18.159% |
| Resverlogix Corp. | -3.61 Million USD | 50.65% |
| Affymax, Inc. | -14.42 Million USD | 87.649% |
| SYBLEU INC | -180.3 Thousand USD | -888.078% |
| Nuo Therapeutics, Inc. | -3.17 Million USD | 43.825% |
| argenx SE | -295.05 Million USD | 99.396% |
| MetaStat, Inc. | - USD | Infinity% |
| Northwest Biotherapeutics, Inc. | -62.59 Million USD | 97.154% |
| Enzon Pharmaceuticals, Inc. | 98 Thousand USD | 1917.902% |
| Arno Therapeutics, Inc. | - USD | Infinity% |
| RespireRx Pharmaceuticals Inc. | -3.97 Million USD | 55.159% |
| GeneThera, Inc. | - USD | Infinity% |
| Inhibitor Therapeutics, Inc. | -3.02 Million USD | 41.128% |
| AVAX Technologies, Inc. | -6.41 Million USD | 72.223% |
| Zenith Capital Corp. | -10.59 Million USD | 83.187% |
| Genscript Biotech Corporation | -95.47 Million USD | 98.134% |
| Ember Therapeutics, Inc. | -23.24 Thousand USD | -7565.192% |
| Anthera Pharmaceuticals, Inc. | - USD | Infinity% |
| Sigyn Therapeutics, Inc. | -4.14 Million USD | 57.029% |
| WPD Pharmaceuticals Inc. | -60.44 Thousand USD | -2847.594% |
| American Oriental Bioengineering, Inc. | -59.72 Million USD | 97.017% |
| Provectus Biopharmaceuticals, Inc. | -3.1 Million USD | 42.564% |
| Adynxx, Inc. | - USD | Infinity% |
| Helix BioMedix, Inc. | -1.05 Million USD | -68.698% |
| GlobeStar Therapeutics Corporation | -1.94 Million USD | 8.604% |
| VitaSpring Biomedical Co. Ltd. | - USD | Infinity% |
| Capstone Therapeutics Corp. | -3.81 Million USD | 53.351% |
| Cotinga Pharmaceuticals Inc. | -2 Million USD | 11.15% |
| BioStem Technologies, Inc. | -8.48 Million USD | 78.999% |
| ONE Bio Corp. | 8.67 Million USD | 120.533% |
| Reve Technologies, Inc. | -441.36 Thousand USD | -303.64% |
| Burzynski Research Institute, Inc. | -1.33 Million USD | -33.406% |
| Wesana Health Holdings Inc. | -1.75 Million USD | -1.526% |
| Agentix Corp. | -1.37 Million USD | -29.641% |
| LadRx Corporation | 400.44 Thousand USD | 544.893% |
| Cell Source, Inc. | -5.32 Million USD | 66.52% |
| ProtoKinetix, Incorporated | -415.47 Thousand USD | -328.793% |
| Regen BioPharma, Inc. | 1.02 Million USD | 274.063% |
| Regen BioPharma, Inc. | 1.02 Million USD | 274.063% |
| NovAccess Global Inc. | -4.76 Million USD | 62.645% |
| Endonovo Therapeutics, Inc. | 6.92 Million USD | 125.728% |
| Itoco Inc. | -1.86 Million USD | 4.679% |
| Rasna Therapeutics, Inc. | -4.44 Million USD | 59.898% |
| Pathfinder Cell Therapy, Inc. | -1.66 Million USD | -6.743% |
| Kadimastem Ltd | -3.3 Million USD | 46.135% |
| Oncology Pharma Inc. | - USD | Infinity% |
| Institute of Biomedical Research Corp. | -273.4 Thousand USD | -551.621% |
| CytoDyn Inc. | -49.84 Million USD | 96.426% |
| Claritas Pharmaceuticals, Inc. | - USD | Infinity% |
| NDT Pharmaceuticals Inc. | -79.03 Thousand USD | -2154.177% |
| Mobile Lads Corp. | -2.26 Million USD | 21.285% |
| NanoSphere Health Sciences Inc. | -228.12 Thousand USD | -680.944% |
| Qrons Inc. | -789.34 Thousand USD | -125.698% |
| Alseres Pharmaceuticals, Inc. | -941.52 Thousand USD | -89.218% |
| Advanced Proteome Therapeutics Corporation | - USD | Infinity% |
| Nascent Biotech, Inc. | -2.08 Million USD | 14.664% |
| Rebus Holdings, Inc. | -1.02 Million USD | -74.661% |
| ImmunoCellular Therapeutics, Ltd. | -1.61 Million USD | -10.467% |
| International Stem Cell Corporation | -131 Thousand USD | -1259.957% |
| Bioxytran, Inc. | -4.28 Million USD | 58.375% |
| GlobeImmune, Inc. | - USD | Infinity% |
| Predictive Technology Group, Inc. | - USD | Infinity% |
| ProText Mobility, Inc. | -54.27 Thousand USD | -3182.621% |
| Cardax, Inc. | - USD | Infinity% |
| VG Life Sciences Inc. | -2.53 Million USD | 29.59% |
| Kaleido Biosciences, Inc. | - USD | Infinity% |
| Advaxis, Inc. | -48.07 Million USD | 96.294% |
| Adhera Therapeutics, Inc. | -2.11 Million USD | 15.726% |
| RenovaCare, Inc. | - USD | Infinity% |
| Regnum Corp. | -780.88 Thousand USD | -128.144% |
| Innovation Pharmaceuticals Inc. | -3.16 Million USD | 43.764% |
| Neutra Corp. | -233.46 Thousand USD | -663.088% |
| Windtree Therapeutics, Inc. | -20.29 Million USD | 91.22% |
| PureTech Health plc | -65.69 Million USD | 97.288% |
| Coeptis Therapeutics, Inc. | -21.26 Million USD | 91.623% |
| IXICO plc | -1.17 Million USD | -51.235% |
| IntelGenx Technologies Corp. | -9.92 Million USD | 82.054% |
| Gelesis Holdings, Inc. | -57.12 Million USD | 96.881% |
| CSL Limited | 2.64 Billion USD | 100.067% |
| Cellectis S.A. | -103.17 Million USD | 98.273% |